134 related articles for article (PubMed ID: 37066234)
1. TREM2 mediates MHCII-associated CD4
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
bioRxiv; 2023 Apr; ():. PubMed ID: 37066234
[TBL] [Abstract][Full Text] [Related]
2. TREM2 mediates MHCII-associated CD4+ T-cell response against gliomas.
Zheng J; Wang L; Zhao S; Zhang W; Chang Y; Bosco DB; Huang T; Dheer A; Gao S; Xu S; Ayasoufi K; Al-Kharboosh R; Qi F; Xie M; Johnson AJ; Dong H; Quiñones-Hinojosa A; Wu LJ
Neuro Oncol; 2024 May; 26(5):811-825. PubMed ID: 37941134
[TBL] [Abstract][Full Text] [Related]
3.
Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
[TBL] [Abstract][Full Text] [Related]
4. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Peshoff MM; Gupta P; Oberai S; Trivedi R; Katayama H; Chakrapani P; Dang M; Migliozzi S; Gumin J; Kadri DB; Lin JK; Milam NK; Maynard ME; Vaillant BD; Parker-Kerrigan B; Lang FF; Huse JT; Iavarone A; Wang L; Clise-Dwyer K; Bhat KP
Neuro Oncol; 2024 May; 26(5):826-839. PubMed ID: 38237157
[TBL] [Abstract][Full Text] [Related]
5. Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Peshoff MM; Gupta P; Trivedi R; Oberai S; Chakrapani P; Dang M; Milam N; Maynard ME; Vaillant BD; Huse JT; Wang L; Clise-Dwyer K; Bhat KP
bioRxiv; 2023 Apr; ():. PubMed ID: 37066184
[TBL] [Abstract][Full Text] [Related]
6. TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages.
Chen X; Zhao Y; Huang Y; Zhu K; Zeng F; Zhao J; Zhang H; Zhu X; Kettenmann H; Xiang X
Glia; 2023 Nov; 71(11):2679-2695. PubMed ID: 37641212
[TBL] [Abstract][Full Text] [Related]
7. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
[TBL] [Abstract][Full Text] [Related]
8. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
[TBL] [Abstract][Full Text] [Related]
9. Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.
Melchior B; Garcia AE; Hsiung BK; Lo KM; Doose JM; Thrash JC; Stalder AK; Staufenbiel M; Neumann H; Carson MJ
ASN Neuro; 2010 Jul; 2(3):e00037. PubMed ID: 20640189
[TBL] [Abstract][Full Text] [Related]
10. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
[TBL] [Abstract][Full Text] [Related]
11. Pon1 Deficiency Promotes Trem2 Pathway-Mediated Microglial Phagocytosis and Inhibits Pro-inflammatory Cytokines Release In Vitro and In Vivo.
Zhang L; Dong W; Ma Y; Bai L; Zhang X; Sun C; Li J; Zhang L
Mol Neurobiol; 2022 Jul; 59(7):4612-4629. PubMed ID: 35589918
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of TREM2 protein during postnatal brain development in mice.
Chertoff M; Shrivastava K; Gonzalez B; Acarin L; Giménez-Llort L
PLoS One; 2013; 8(8):e72083. PubMed ID: 23977213
[TBL] [Abstract][Full Text] [Related]
13. Surface TREM2 on circulating M-MDSCs as a novel prognostic factor for adults with treatment-naïve diffuse large B-cell lymphoma.
Wang HY; Yang FC; Yang CF; Liu YC; Ko PS; Li CJ; Tsai CK; Chung YL; Chen NJ
Exp Hematol Oncol; 2023 Apr; 12(1):35. PubMed ID: 37029450
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of triggering receptor expressed on myeloid cell-2 in malignant tumor.
Wang Y; Chu Y; Cao F; Chen Z; Xu H; Wang S; Ma J
Cent Eur J Immunol; 2022; 47(4):373-381. PubMed ID: 36817396
[TBL] [Abstract][Full Text] [Related]
15. TREM2
Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
[TBL] [Abstract][Full Text] [Related]
16. Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer's Disease Brain.
Korvatska O; Kiianitsa K; Ratushny A; Matsushita M; Beeman N; Chien WM; Satoh JI; Dorschner MO; Keene CD; Bammler TK; Bird TD; Raskind WH
Front Immunol; 2020; 11():559342. PubMed ID: 33101276
[TBL] [Abstract][Full Text] [Related]
17. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immunological features of TREM1 and its emergence as a prognostic indicator in glioma.
Zhang L; Qu X; Xu Y
Front Immunol; 2024; 15():1324010. PubMed ID: 38370418
[TBL] [Abstract][Full Text] [Related]
19. TREM2 deficiency in microglia accelerates photoreceptor cell death and immune cell infiltration following retinal detachment.
Zhou W; Zhou Y; He J; Rao Y; Fei P; Li J
Cell Death Dis; 2023 Mar; 14(3):219. PubMed ID: 36977680
[TBL] [Abstract][Full Text] [Related]
20. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
